Diltiazem Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-816 -
Package NDC
62332-816-31 -
Package NDC
62332-816-71 -
Package NDC
62332-816-91 -
Application number
ANDA218587 -
SPL ID
e01b87fe-c495-4a9f-8195-2b6728d738d4 -
SPL set ID
04a85be5-f746-418e-8e37-292703f16934 -
UNII
OLH94387TE -
RxCUI
830837 -
RxCUI
830845 -
RxCUI
830861
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- Diltiazem Hydrochloride
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Diltiazem Hydrochloride",
"splId": "e01b87fe-c495-4a9f-8195-2b6728d738d4",
"labels": [
{
"setId": "04a85be5-f746-418e-8e37-292703f16934",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=04a85be5-f746-418e-8e37-292703f16934",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=04a85be5-f746-418e-8e37-292703f16934"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-816-31)",
"package_ndc": "62332-816-31",
"identifierStatus": "well-formed",
"marketing_start_date": "20241028"
},
{
"sample": false,
"description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-816-71)",
"package_ndc": "62332-816-71",
"identifierStatus": "well-formed",
"marketing_start_date": "20241028"
},
{
"sample": false,
"description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-816-91)",
"package_ndc": "62332-816-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20241028"
}
],
"productId": "62332-816_e01b87fe-c495-4a9f-8195-2b6728d738d4",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "62332-816",
"deaSchedule": null,
"genericName": "Diltiazem Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DILTIAZEM HYDROCHLORIDE",
"strength": "180 mg/1"
}
],
"applicationNumber": "ANDA218587",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20241028",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0362332816316",
"0362332815319"
],
"unii": [
"OLH94387TE"
],
"rxcui": [
"830837",
"830845",
"830861"
],
"spl_set_id": [
"04a85be5-f746-418e-8e37-292703f16934"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-816_e01b87fe-c495-4a9f-8195-2b6728d738d4"